Kintara Therapeutics News

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Laura L.

Sep 1, 2023 18:00 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FAVORITO TAMARA A

Sep 1, 2023 18:00 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hoffman Robert E.

Sep 1, 2023 18:00 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TOTH ROBERT JOSEPH JR

Sep 1, 2023 18:00 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Dennis M

Sep 1, 2023 18:00 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hoffman Robert E.

Jun 2, 2023 16:05 ET

Kintara Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0.1%),Lind Global Partners II LLC(0.1%), etc.

Feb 13, 2023 16:29 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 6, 2023 19:26 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 3, 2022 16:30 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 3, 2022 16:30 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 3, 2022 16:30 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jul 5, 2022 16:05 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jul 5, 2022 16:05 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jul 5, 2022 16:05 ET

Kintara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.8%),Lind Global Partners II LLC(5.8%), etc.

Apr 20, 2022 17:11 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 17, 2022 16:00 ET

Kintara Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Carolyn A. Pilkiewicz(2.41%),Michael B. DeGidio(2.38%), etc.

Feb 7, 2022 13:26 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Dec 9, 2021 16:09 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Dec 8, 2021 16:09 ET

Kintara Therapeutics | 4: Statement of changes in beneficial ownership of securities

Nov 24, 2021 16:06 ET